psilocybin (COMP360) / Compass Pathways  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
psilocybin (COMP360) / Compass Pathways
NCT06258031: PsilOCD: A Pharmacological-Challenge Feasibility Study

Recruiting
1
20
Europe
Psilocybin (COMP360), O-phosphoryl-4-hydroxy-N,N-dimethyltryptamine
Imperial College London
Obsessive-Compulsive Disorder
06/24
07/24

Download Options